RT Journal Article
SR Electronic
T1 Study protocol for a pilot clinical trial to understand neural mechanisms of response to a psychological treatment for pain and anxiety in pediatric functional abdominal pain disorders (FAPD)
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.02.08.24302498
DO 10.1101/2024.02.08.24302498
A1 Cunningham, Natoshia R.
A1 Adler, Michelle A.
A1 Barber Garcia, Brittany N.
A1 Abounader, Taylor
A1 Miller, Alaina K.
A1 Monzalvo, Mariela
A1 Hashemi, Ismaeel
A1 Cox, Ryan
A1 Ely, Samantha L.
A1 Zhou, Yong
A1 DeLano, Mark
A1 Mulderink, Todd
A1 Reeves, Mathew J.
A1 Peugh, James L.
A1 Kashikar-Zuck, Susmita
A1 Coghill, Robert C.
A1 Arnetz, Judith E.
A1 Zhu, David C.
YR 2024
UL http://medrxiv.org/content/early/2024/02/09/2024.02.08.24302498.abstract
AB Background Functional abdominal pain disorders (FAPD) are the most common chronic pain conditions of childhood and are made worse by co-occurring anxiety. Our research team found that the Aim to Decrease Pain and Anxiety Treatment (ADAPT), a six-session coping skills program using cognitive behavioral therapy strategies, was effective in improving pain-related symptoms and anxiety symptoms compared to standard care. In follow-up, this current randomized clinical trial (RCT) aims to test potential neural mechanisms underlying the effect of ADAPT. Specifically, this two-arm RCT will explore changes in amygdalar functional connectivity (primary outcome) following the ADAPT protocol during the water loading symptom provocation task (WL-SPT). Secondary (e.g., changes in regional cerebral blood flow via pulsed arterial spin labeling MRI) and exploratory (e.g., the association between the changes in functional connectivity and clinical symptoms) outcomes will also be investigated.Methods We will include patients ages 11 to 16 years presenting to outpatient pediatric gastroenterology care at a midwestern children’s hospital with a diagnosis of FAPD plus evidence of clinical anxiety based on a validated screening tool (the Generalized Anxiety Disorder-7 [GAD-7] measure). Eligible participants will undergo baseline neuroimaging involving the WL-SPT, and assessment of self-reported pain, anxiety, and additional symptoms, prior to being randomized to a six-week remotely delivered ADAPT program plus standard medical care or standard medical care alone (waitlist). Thereafter, subjects will complete a post assessment neuroimaging visit similar in nature to their first visit.Conclusions This small scale RCT aims to increase understanding of potential neural mechanisms of response to ADAPT. ClinicalTrials.gov registration: NCT03518216Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT03518216Clinical Protocols https://classic.clinicaltrials.gov/ProvidedDocs/16/NCT03518216/Prot_SAP_000.pdf Funding StatementYesAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study is approved by Michigan State University’s institutional review board, with Helen DeVos Children’s Hospital/Corewell Health relying on the primary IRB.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Not ApplicableNo datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.